Coronary artery disease
Conditions
Interventions
BRILINTA:Initiate BRILINTA treatment with a 180 mg (two 90 mg tablets) loading dose and continue treatment with 90 mg twice daily.
Plavix:Initiate Plavix treatment with a 300 mg (four 75 mg tablets) loading dose and continue treatment with 75 mg daily.
Sponsors
Nanjing First Hospital, Nanjing Medical Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Established indication to PCI according to the guidelines of China Heart Association guidelines of American Heart Association, and American College of Cardiology; 2. Aged > 18 years, written consent; 3. Native coronary lesion suitable for stent placement and OCT imaging.
Exclusion criteria
Exclusion criteria: General exclusion criteria: 1. Pregnancy and breast feeding mother; 2. Co-morbidity with an estimated life expectancy of 30 mm.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subclinical Thrombum; | — |
Countries
China
Contacts
Public ContactShaoliang Chen
Nanjing First Hospital, Nanjing Medical Hospital
Outcome results
None listed